SUMMARY Two colour flow cytometry techniques were used to assess the activation stages of peripheral and intraocular T lymphocytes in uveitis. Increased numbers of T lymphocytes bearing the interleukin-2 (IL-2) receptors were found in intraocular fluids or peripheral blood or both of 35/ 51 patients with uveitis. This increased expression of IL-2 receptors on lymphocytes correlated with increased expression of other early T lymphocyte activation markers, HLA-DR and L-35. Both T helper cells (Leu-3A+) and suppressor cells (Leu 2A+) were activated in vivo. A positive correlation was seen between lymphocyte activation and clinical uveitis activity. In idiopathic uveitis activation of Leu-3A lymphocytes (helper/inducer) was significantly increased, and intraocular activation of the Leu-2A lymphocytes (cytotoxic/suppressor) was significantly decreased. These data show that some patients with idiopathic uveitis have a perturbation of T helper cells. Twenty-two of 31 patients with idiopathic uveitis, not associated with systemic disease, had increased peripheral T lymphocyte activation. This finding indicates that in some inflammations believed to be restricted to the eye an abnormal systemic immune activation exists.
Immunological abnormalities important in the pathogenesis and pathophysiology of uveitis are poorly defined. ' We and others have used flow cytometry to characterise the nature of intraocular lymphocyte subpopulations in uveitis patients.2' The role of intraocular lymphocytes in uveitis is not clear. We have previously shown that many intraocular lymphocytes are present secondary to blood ocular barrier breakdown.4 However, whether these cells are passive, or actively involved in the pathophysiology of the disease, is uncertain.
Newer techniques can be used to distinguish activated lymphocytes capable of mediating immunological events from resting T cells. Activation of human T lymphocytes results in the expression of interleukin-2 receptors and HLA-DR on their surfaces; these antigens are present in minute quantities on resting T cells.-In some immunologically mediated diseases activated T cells are markedly increased at the site of inflammation.89 In both rheumatoid arthritis and spondylitis significantly more activated T cells are present in synovium than in the blood. ' In multiple sclerosis an increase of activated T cells in the peripheral blood is consistent with systemic immune activation.9
Correspondence to Devron H Char, MD, Ocular Oncology Unit, Science 315, University of California, San Francisco CA94143, USA. In this study we examined uveitis patients with known systemic syndromes or idiopathic intraocular inflammation for the presence of interleukin-2 receptors and other early activation markers on T cells from intraocular fluids and peripheral blood. These studies were performed to determine the frequency of in-vivo T lymphocyte activation in uveitis and its correlation with disease activity.
Subjects and methods
Patients were examined and studied in the Uveitis Survey Unit of the Francis I Proctor Foundation. Ocular diagnoses were made on the basis of history, clinical examination, and routine laboratory tests. A diagnosis of idiopathic uveitis was made in the absence of a known clinical uveitis syndrome, systemic disease, or laboratory abnormalities. The diagnosis of HLA-B27 related uveitis was made in anterior uveitis patients who were HLA-B27 positive.
The severity of inflammation was graded by summing numerical values assigned to the various clinical factors of uveitis"": anterior chamber cells and flare (0 to 4), keratic precipitates (0 or 1), vitreous reaction (O to 4), cystoid macular oedema, optic nerve oedema, and vasculitis (0 to 4).
Aqueous and vitreous specimens were obtained as previously described after informed consent was 83 received. 4 Pars planitis (Table 4) . expressions are shown in Table 2 . A positive correlation was seen between aqueous Uveitis patients had significantly more activated T T lymphocyte activation and peripheral blood T cells (IL-2R positive) in the blood than healthy lymphocyte activation (Leu-2A correlation=0-714; controls (p<005). Thirteen of 17 patients with systemic uveitis syndromes and 22 of 31 patients with Table 2 Control population idiopathic uveitis had increased IL-2R expression on Leu-4+ cells (Fig. 2) .
The majority of cells in aqueous and vitreous of surface uveitis patients were T cells. Table 3 enumerates the antigens total T, total B, and T cell subsets in both the intraocular components and peripheral blood in 2A Using a Kendal TB analysis we found a statistically significant correlation between clinical uveitis ND=not done.
activity and the percentage of activated T cells in both ± is followed by standard deviation. Increased expression of the other early activation markers correlated well with increased expression of IL-2 receptors on T lymphocytes (HLA-DR: correlation=0-412, p=00008; L-35: correlation=0-567; L-36: correlation=0-411, p=00024) ( Table 4) .
The diagnosis of idiopathic uveitis correlated with increased expression of the IL-2 receptors on peripheral Leu-3A+ lymphocytes (correlation= 0-247, p=0-033). No correlation was seen between increased IL-2 receptors expression on peripheral Leu-2A+ lymphocytes (correlation=0-08, p=O5) and the diagnosis of idiopathic uveitis; a negative correlation was seen between increased IL2+Leu 2A lymphocytes in aqueous and the diagnosis of idiopathic uveitis (correlation: -0572, p=0-049).
Discussion
We demonstrated activated T cells in aqueous, vitreous, and peripheral blood of uveitis patients using an anti-interleukin-2 receptor monoclonal antibody. Expression of IL-2 receptors on lymphocytes correlated with the expression of other early activation markers: HLA-DR, L-35, and L-36. The degree of T cell activation correlated with clinical uveitis activity.
In peripheral blood both patients with systemic syndromes associated with intraocular inflammation and patients with idiopathic uveitis had significantly more activated T cells than healthy controls. These data show systemic T cell activation in at least a subset of idiopathic uveitis patients.
We and others have previously found evidence of systemic immune response in some idiopathic uveitis patients. Kauhn et al. 13 Our findings suggest that some idiopathic uveitis may be systemic diseases with mainly ocular signs and symptoms. The aetiology for systemic lymphocyte activation in ocular inflammatory disease is uncertain. Lymphocytes could be activated locally, and the systemic lymphocyte activation observed might represent spillover from the eye. However, it seems improbable that a small organ like the eye would be able to generate the amount of activated lymphocytes seen in the systemic circulation. Probably this perturbation of the immune system is due either to an abnormality of immunoregulatory homoeostasis or to altered immunological reactivity towards uveogenic antigens. Our findings indicate that a perturbation of the systemic T helper cells is present in some patients suffering from idiopathic uveitis. Recently, Caspi and coworkers established a uveogenic T helper lymphocyte line capable of transferring experimental autoimmune uveoretinitis (EAU) in the rat.'8 With regard to these findings it is tempting to postulate that some idiopathic uveitis could be a 'T helper mediated disorder'. Further studies are necessary to delineate the relative importance of these mechanisms as well as to determine the relative contribution of intraocular versus systemic lymphocyte activation in uveitis.
